APA (7th ed.) Citation

WM, H., LAA, B., JY, K., R, O., YN, S., TC, L., . . . AD, S. (2022). Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size. Gut, 71(5), 961. https://doi.org/10.1136/gutjnl-2020-322595

Chicago Style (17th ed.) Citation

WM, Hackeng, et al. "Non-functional Pancreatic Neuroendocrine Tumours: ATRX/DAXX and Alternative Lengthening of Telomeres (ALT) Are Prognostically Independent from ARX/PDX1 Expression and Tumour Size." Gut 71, no. 5 (2022): 961. https://doi.org/10.1136/gutjnl-2020-322595.

MLA (9th ed.) Citation

WM, Hackeng, et al. "Non-functional Pancreatic Neuroendocrine Tumours: ATRX/DAXX and Alternative Lengthening of Telomeres (ALT) Are Prognostically Independent from ARX/PDX1 Expression and Tumour Size." Gut, vol. 71, no. 5, 2022, p. 961, https://doi.org/10.1136/gutjnl-2020-322595.